Actionable news
All posts from Actionable news
Actionable news in ZFGN: ZAFGEN Inc,

Why Regado Biosciences (RGDO) Stock Hit a One-Year Low Today

NEW YORK (TheStreet) -- Regado Biosciences (RGDO) plummeted to a new 52-week low of $1.12 on Monday after the company canceled a late-stage trial of its blood clot drug Revolixys, which combats coronary artery disease.

The trial's data and safety monitoring board "indicated that the level of serious allergic adverse events associated with Revolixys was of a frequency and severity such that they recommended that we do not enroll any further patients in the Regulate-PCI...